Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EGFL7 is a secreted protein primarily expressed by endothelial cells and plays a critical role in blood vessel development during both physiological and pathological angiogenesis. It modulates Notch signaling and influences key processes like angiogenesis, vasculogenesis, and neurogenesis. Aberrant expression is linked to tumor angiogenesis, growth, and metastasis across several cancers.
Modulates Notch signaling; promotes endothelial cell migration, proliferation, and sprouting; enhances EGF receptor-AKT signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal Growth Factor-Like Domain Multiple 7 (EGFL7).